Scaling Up for First Product Launch: Seven Hazards to Avoid Pierre Jacquet, M.D., Ph.D. Peter Rosenorn Aditya Natarajan Read more
Related Practice Life Sciences & Pharma As the margin for error in the drug launch cycle continues to erode, emerging biopharma companies face a growing urgency to double down on scaling up for that first launch. 06192019150626
Podcast Biotech and Pharmaceuticals Five Essential Factors for a Successful Biopharma Product Launch March 23, 2023
Video / Webinar MedTech APAC Hospital Priorities 2022: Strategic Implications for Medtech Firms Part 3 July 29, 2022
Special Report Life Sciences & Pharma Viral-Based Gene Therapy: Key Challenges and Bioprocessing Innovations December 16, 2022
Executive Insights Life Sciences & Pharma Move Precision Medicine Beyond Oncology: Keys to Successful Enterprise-Level Strategy November 4, 2022